These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

180 related items for PubMed ID: 23276900

  • 21. Assessment of combination of contrast-enhanced magnetic resonance imaging and positron emission tomography/computed tomography for evaluation of ovarian masses.
    Tsuboyama T, Tatsumi M, Onishi H, Nakamoto A, Kim T, Hori M, Sakane M, Hori Y, Morii E, Hatazawa J, Tomiyama N.
    Invest Radiol; 2014 Aug; 49(8):524-31. PubMed ID: 24637584
    [Abstract] [Full Text] [Related]

  • 22. Differentiation of FDG-avid loco-regional recurrent and compromised benign lesions after surgery for breast cancer with dual-time point F-18-fluorodeoxy-glucose PET/CT scan.
    Suga K, Kawakami Y, Hiyama A, Matsunaga N.
    Ann Nucl Med; 2009 Jun; 23(4):399-407. PubMed ID: 19452249
    [Abstract] [Full Text] [Related]

  • 23. Temporal profile of fluorodeoxyglucose uptake in malignant lesions and normal organs over extended time periods in patients with lung carcinoma: implications for its utilization in assessing malignant lesions.
    Basu S, Kung J, Houseni M, Zhuang H, Tidmarsh GF, Alavi A.
    Q J Nucl Med Mol Imaging; 2009 Feb; 53(1):9-19. PubMed ID: 18337683
    [Abstract] [Full Text] [Related]

  • 24. The clinical value of dual-time point 18F-FDG PET/CT for differentiating extrahepatic cholangiocarcinoma from benign disease.
    Choi EK, Yoo IeR, Kim SH, O JH, Choi WH, Na SJ, Park SY.
    Clin Nucl Med; 2013 Mar; 38(3):e106-11. PubMed ID: 23354026
    [Abstract] [Full Text] [Related]

  • 25. PET/CT for the characterization of adrenal masses in patients with cancer: qualitative versus quantitative accuracy in 150 consecutive patients.
    Boland GW, Blake MA, Holalkere NS, Hahn PF.
    AJR Am J Roentgenol; 2009 Apr; 192(4):956-62. PubMed ID: 19304700
    [Abstract] [Full Text] [Related]

  • 26. The clinical value of fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography in postoperative patients with gastrointestinal mucinous adenocarcinoma.
    Yang ZY, Hu SL, Shi W, Zhu BL, Xu JY, Zhang YJ.
    Nucl Med Commun; 2011 Nov; 32(11):1018-25. PubMed ID: 21956489
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Adrenal nodules at FDG PET/CT in patients known to have or suspected of having lung cancer: a proposal for an efficient diagnostic algorithm.
    Brady MJ, Thomas J, Wong TZ, Franklin KM, Ho LM, Paulson EK.
    Radiology; 2009 Feb; 250(2):523-30. PubMed ID: 19188319
    [Abstract] [Full Text] [Related]

  • 29. (18)F-FDG PET-CT respiratory gating in characterization of pulmonary lesions: approximation towards clinical indications.
    García Vicente AM, Soriano Castrejón AM, Talavera Rubio MP, León Martín AA, Palomar Muñoz AM, Pilkington Woll JP, Poblete García VM.
    Ann Nucl Med; 2010 Apr; 24(3):207-14. PubMed ID: 20177834
    [Abstract] [Full Text] [Related]

  • 30. Diagnostic accuracy of dual-time-point 18F-FDG PET/CT for the detection of axillary lymph node metastases in breast cancer patients.
    Hahn S, Hecktor J, Grabellus F, Hartung V, Pöppel T, Kimmig R, Forsting M, Antoch G, Heusner TA.
    Acta Radiol; 2012 Jun 01; 53(5):518-23. PubMed ID: 22547387
    [Abstract] [Full Text] [Related]

  • 31. Texture analysis on (18)F-FDG PET/CT images to differentiate malignant and benign bone and soft-tissue lesions.
    Xu R, Kido S, Suga K, Hirano Y, Tachibana R, Muramatsu K, Chagawa K, Tanaka S.
    Ann Nucl Med; 2014 Nov 01; 28(9):926-35. PubMed ID: 25107363
    [Abstract] [Full Text] [Related]

  • 32. Diagnostic values of delayed additional FDG PET/CT scan in the evaluation of cardiac sarcoidosis.
    Manabe O, Takahashi K, Kawakami H, Ohtsuka A, Aikawa T, Maki H, Ibe T, Fujita H, Oyama-Manabe N.
    Ann Nucl Med; 2023 Oct 01; 37(10):535-540. PubMed ID: 37418117
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. [Value of (18)F-FDG PET-CT in the preoperative N staging of non-small cell lung cancer].
    Li M, Wu N, Liang Y, Zheng R, Liu Y, Zhang WJ, Zhao P.
    Zhonghua Zhong Liu Za Zhi; 2009 Apr 01; 31(4):288-92. PubMed ID: 19615286
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Dual-time-point FDG PET/CT for the evaluation of pediatric tumors.
    Costantini DL, Vali R, Chan J, McQuattie S, Charron M.
    AJR Am J Roentgenol; 2013 Feb 01; 200(2):408-13. PubMed ID: 23345365
    [Abstract] [Full Text] [Related]

  • 39. 18F-FDG PET/CT for the prediction and detection of local recurrence after radiofrequency ablation of malignant lung lesions.
    Singnurkar A, Solomon SB, Gönen M, Larson SM, Schöder H.
    J Nucl Med; 2010 Dec 01; 51(12):1833-40. PubMed ID: 21078787
    [Abstract] [Full Text] [Related]

  • 40. Diagnostic accuracy of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography in differentiated thyroid cancer patients with elevated thyroglobulin and negative (131)I whole body scan: evaluation by thyroglobulin level.
    Na SJ, Yoo IeR, O JH, Lin C, Lin Q, Kim SH, Chung SK.
    Ann Nucl Med; 2012 Jan 01; 26(1):26-34. PubMed ID: 21971605
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.